Module

Hepatitis C Treatment: Today and Tomorrow

Source: Hepatitis Annual Update 2004

Hepatitis C Treatment: Today and Tomorrow


Program Director: John P. Phair, MD

Faculty:

  • Michael W. Fried, MD

CME CREDIT INFORMATION

Release Date: 09/10/04

Expiration Date: 09/09/05


Physicians: maximum of 0.5 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss the latest data about new drugs in development for the treatment of HCV infection

  • Describe current options for the treatment and management of chronic HCV infection

  • Evaluate strategies to improve treatment adherence and outcomes


Content includes:

  • Current Therapy for Hepatitis C
  • Early Virologic Response
  • Limitations of EVR
  • New Directions in HCV Therapy
  • Normal ALT
  • New Agents for the Treatment of HCV
  • New Targets
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Northwestern University’s Feinberg School of Medicine and Clinical Care Options, LLC.

Educational grant provided by:

Educational grants support only the CME-certified components of this program.